Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Icos acquires rights to resiniferatoxin for urological disorders

Nov. 8, 2001

New potassium channel openers and uses thereof reported by Abbott team

Oct. 31, 2001

Dual M3 and 5-HT4 antagonists claimed in recent patent by Sanofi-Synthelabo

Oct. 29, 2001

Compound for SIADH designated an orphan drug in Japan

Oct. 25, 2001

Long-term tamsulosin has sustained efficacy, safety in LUTS/BPH

Oct. 23, 2001

U.S. phase III efficacy and safety data for Foznol discussed at World Congress of Nephrology

Oct. 19, 2001

Fujisawa identifies new aminoalcohol beta3-adrenoceptor agonists

Oct. 18, 2001

GSK seeks Swedish approval of dutasteride for treatment of BPH

Oct. 18, 2001

FDA issues approvable letter for UroXatral

Oct. 15, 2001

Beta3-adrenoceptor agonists and use in urinary incontinence, obesity and diabetes

Oct. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...